Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 16:10:134.
doi: 10.1186/1471-2458-10-134.

Hormone replacement therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain

Elisa Chilet-Rosell  1 , Marta Martín Llaguno, María Teresa Ruiz Cantero, Pablo Alonso-Coello
Affiliations

Hormone replacement therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain

Elisa Chilet-Rosell et al. BMC Public Health. .

Abstract

Background: The balance of the benefits and risks of long term use of hormone replacement therapy (HRT) have been a matter of debate for decades. In Europe, HRT requires medical prescription and its advertising is only permitted when aimed at health professionals (direct to consumer advertising is allowed in some non European countries). The objective of this study is to analyse the appropriateness and quality of Internet advertising about HRT in Spain.

Methods: A search was carried out on the Internet (January 2009) using the eight best-selling HRT drugs in Spain. The brand name of each drug was entered into Google's search engine. The web sites appearing on the first page of results and the corresponding companies were analysed using the European Code of Good Practice as the reference point.

Results: Five corporate web pages: none of them included bibliographic references or measures to ensure that the advertising was only accessible by health professionals. Regarding non-corporate web pages (n = 27): 41% did not include the company name or address, 44% made no distinction between patient and health professional information, 7% contained bibliographic references, 26% provided unspecific information for the use of HRT for osteoporosis and 19% included menstrual cycle regulation or boosting feminity as an indication. Two online pharmacies sold HRT drugs which could be bought online in Spain, did not include the name or contact details of the registered company, nor did they stipulate the need for a medical prescription or differentiate between patient and health professional information.

Conclusions: Even though pharmaceutical companies have committed themselves to compliance with codes of good practice, deficiencies were observed regarding the identification, information and promotion of HRT medications on their web pages. Unaffected by legislation, non-corporate web pages are an ideal place for indirect HRT advertising, but they often contain misleading information. HRT can be bought online from Spain, without a medical consultation or prescription constituting a serious issue for public health. In our information society, it is the right and obligation of public health bodies to ensure that such information is not misleading.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Selection of Web of best selling HRT drugs in Spain to be analysed.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Krieger N, Löwy I, Aronowitz R, Bigby J. et al.Hormone replacement therapy, cancer, controversies and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J Epidemiol Community Health. 2005;59:740–48. doi: 10.1136/jech.2005.033316. - DOI - PMC - PubMed
    1. Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA. 2002;288:321–333. doi: 10.1001/jama.288.3.321. - DOI - PubMed
    1. Grady D, Applegate W, Bush TL, Furberg C, Riggs B, Hulley S. Heart and Estrogen/Progestin Replacement Study (HERS): Design, methods and baseline characteristics. Control Clin Trials. 1998;19:314–35. doi: 10.1016/S0197-2456(98)00010-5. - DOI - PubMed
    1. Chilibeck PD. Exercise and Estrogen or Estrogen Alternatives (Phytoestrogens, Biphosphonates) for Prevention of Bone Mineral in Postmenopausal Women. Canadian Journal of Applied Physiology. 2004;29:59–75. doi: 10.1139/h04-006. - DOI - PubMed
    1. US Preventive Services Task Force. Agency for Healthcare Research and Quality. Rockville MD: Hormone Replacement Therapy for the Prevention of Chronic Conditions in Postmenopausal Women. Topic Page. 2005. http://ahrq.gov/clinic/uspstf/uspspmho.htm

Publication types